HIKAL LIMITED Intrinsic Value

HIKAL · Healthcare · Current price ₹201.98

Full stock page
DocStoX fair value
₹145
low confidence
Current price
₹202
Upside to fair value
-28.1%
Verdict
Expensive
Quality score
3.0 / 10
Model it yourself — Intrinsic Value Calculator
Opens pre-filled with HIKAL LIMITED's latest numbers.

Is HIKAL LIMITED undervalued?

DocStoX estimates the fair value of HIKAL LIMITED at ₹145 per share, versus the current market price of ₹202. That puts the stock about -28.1% above our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.

How this fair value is calculated

This estimate blends 2 independent methods: Residual income (₹85), Analyst target (₹300). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹85 (bear) to ₹145 (base) to ₹300 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Margin of safety

Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹202 versus an intrinsic value of ₹145, HIKAL LIMITED currently offers -28.1% of negative margin (i.e. a premium).

More on HIKAL LIMITED

Fair ValueDCFValuationFinancial RatiosPeers

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.